Taking peopleNo phase
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Key facts
- Who runs it
- Association HGE CHU Bordeaux Sud
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- Feb 2014
- Expected to end
- Feb 2034
- Type of study
- Observational
- Record updated
- 20 July 2023
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- chronic hepatitis C
- chronic hepatitis B
- alcohol liver disease
- non alcoholic liver disease
Who cannot take part
- ascitis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.
The group in the trial
- Chronic liver disease
all patients with chronic liver disease followed using non-invasive methods
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.
- Record updated
- 20 July 2023